Clinical Trial Update: MitoQ for Fatigue in Multiple Sclerosis (MS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating MitoQ for fatigue in multiple sclerosis completed; results were posted on 2025-10-29.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MitoQ

Snippet

Sponsor: VA Office of Research and Development | Conditions: Multiple Sclerosis, Fatigue | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-29